Product dossierBuilt from registrations, label text and platform-curated data

Revanesse OutlineRevanesse Oultine 1.2 mL

Revanesse Outline is a Skin booster product (Class III device), registered by Prollenium Medical Technologies Inc.. Linked registrations: EU B-PN40115PV, EU B-PN40141PW, EU B-PN40142PY and 5 more. Data as of 2026-11-09.

  • Regulatory classSkin booster · Class III device
  • HolderProllenium Medical Technologies Inc.
  • JurisdictionsEU · UK · AU
  • Updated2026-11-09 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

Revanesse Outline

Product
Regulatory class
Class III device
Category
Skin booster
EU · EUDAMED device record
B-PN40115PV
EU · EUDAMED device record
B-PN40141PW
EU · EUDAMED device record
B-PN40142PY
EU · EUDAMED device record
B-PN40143Q2
EU · EUDAMED device record
B-PN40145Q6
EU · EUDAMED device record
B-PN40146Q8
EU · EUDAMED device record
B-PN40147QA
EU · EUDAMED device record
B-PN40148QC
Other registrations
7 more, see the timeline
Name on registration
Revanesse® Outline + with Lidocaine 1.2 mL
Registrant
Prollenium Medical Technologies Inc.
EU authorised representative
Emergo Europe B.V.(NL-AR-000000116)
First approval
Not obtained from an official source
Checked against official page
Not yet checked field by field against the live official page

Public: fields from the registration record.Registrant and dates are from B-PN40115PV; 15 registrations linked.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. UK

    PARD-2146009 registered

  2. UK

    PARD-2146016 registered

  3. UK

    PARD-2146033 registered

  4. UK

    PARD-3283634 registered

  5. UK

    PARD-3315949 registered

  6. UK

    PARD-3315951 registered

  7. AU

    450109 ARTG start date

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record. Dates on non-Chinese registrations keep the source's wording: UK devices show the registration date (MHRA does not approve them), Australia the ARTG start date, FDA devices the decision date.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

5
  • PARD-3315949: registered2022-07-19
  • PARD-3315951: registered2022-07-19
  • PARD-3283634: registered2022-07-01
  • PARD-2146016: registered2021-12-02
  • PARD-2146033: registered2021-12-02

Sources

15